Levi & Korsinsky announces it has commenced an investigation of PAREXEL International Corporation (NASDAQ: PRXL) ("PAREXEL") concerning possible violations of federal securities laws by the Company and/or certain of its officers and directors. On August 30, 2016, PAREXEL announced that it would be delaying its 2016 Form 10-K filing after it received a report "of an incident of misappropriation of corporate funds by an employee in one of the Company's international operations." Then on November 10, 2016, PAREXEL notified the SEC that it would not be filing its Quarterly Report for the fiscal quarter ended September 30, 2016 in a timely fashion. According to a filing with the SEC, the delay results from the identification of "potential errors related to the timing of revenue recognition, almost all related to prior periods, with regard to its [the Company's] Clinical Research Services business segment." To obtain additional information, go to: http://zlk.9nl.com/parexel-prxl or contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.